Diabetes on the Net is intended for healthcare professionals

Click here to view prescribing information and adverse event reporting information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.

The promotional content on this page and respective materials have been developed, organised and funded by Novo Nordisk.

For healthcare professionals only. Promotional information on Novo Nordisk products may be mentioned.

Diabetes
and
vulnerable populations

on-demand

Resource Centre

This resource centre comprises of a range of materials designed to enable reflection and discussion on diabetes and vulnerable populations. 

This promotional webinar series and respective materials have been developed, organised and funded by Novo Nordisk. For healthcare professionals only. Promotional information on Novo Nordisk products may be mentioned.

Click here to view prescribing information and adverse event reporting information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.

Diabetes and mental health

Case Studies

Watch these short case study videos of fictitious patients with diabetes who have struggled with mental health problems, and consider how you might diagnose their conditions along with appropriate treatment options.
These images are not of actual patients